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Purpose. Acetylcholinesterase (AChE) inhibitors are used to treat Alzheimer’s patients because they enhance cholinergic
neurotransmission. It is urgent to find new and efficient inhibitors from natural sources, highly bioavailable with low or no
toxicity. +e plant kingdom is extremely rich in a variety of compounds that are potent AChE inhibitors: flavonoids and other
phenolic compounds have been recognized as promising Alzheimer’s treatment agents. In this study, in vitro acetylcholinesterase
inhibition, antioxidant activities, and total flavonoid and phenolic contents of ethanol-water extracts fromQuercus suber cork and
corkback were evaluated. Methods. +e acetylcholinesterase activity was determined by a colorimetric assay based on Ellman’s
methodology. +e Folin–Ciocalteu colorimetric method was used for total phenolic content determination and the aluminium
chloride method for the determination of total flavonoid content. Antioxidant activity assays were performed using the DPPH and
FRAP assays. Results. +e acetylcholinesterase inhibitory activity from Q. suber cork and corkback ethanol-water extracts was as
follows: 62% inhibition with corkback extracts over 0.5mg/mL and around 49% inhibition in cork extracts over 1.0mg/mL
extracts’ concentration. Regarding the DPPH radical scavenging activity, the concentrations of cork and corkback ethanol-water
extracts required for 50% DPPH inhibition (IC50) were 3.2 μg/mL and 4.0–5.2 μg/mL. Corkback extracts are less effective than
Trolox standard (3.2 μg/mL) but cork extracts showed the same free radical scavenging activity compared to Trolox. Cork and
corkback extracts have antioxidant power of 750.9–775.4mg TEAC/g extract and 1051.2–2052.4mg TEAC/g extract, respectively,
which are significantly higher than the ones obtained with Trolox: 19.6–21.0mg TEAC/g extract (cork assays) and 57.4–66.3mg
TEAC/g extract (corkback assays).+e amounts of total phenolic (TPC) and flavonoid (TFC) compounds were 8.7–32.3mg GAE/
g and 4.8–10.7mg CE/g dry mass for cork and 5.4–5.7mg GAE/g and 42.5mg CE/g dry mass for corkback extracts, respectively,
using catechin (CE) and GAE (gallic acid) as standards. Conclusion. +ese findings demonstrate the remarkable potential of these
extracts as valuable source of antioxidants with interesting acetylcholinesterase inhibitory activity.
1. Introduction
Medicinal plants are used by a large share of the world
population as a source of therapeutic agents for their
primary health care [1–3]. Some secondary metabolites of
plants are bioactive compounds used for the treatment of
several diseases, e.g., to fight the damage caused by re-
active oxygen species resulting in several human pa-
thologies such as arthritis, cancer, inflammatory
conditions, or heart disease [4, 5]. Sources of free radicals
involved in this oxidative stress are chemical products,
toxins, radiation, pollution, agriculture toxics, and pre-
servatives used in foods [6].
Phenols and flavonoids may have the potential to
function as antioxidants by scavenging free radicals via
hydrogenation or complexation with oxidizing species due
to their conjugated ring structures and hydroxyl groups [6].
In the recent decades, natural products and drugs derived
from natural products have become a research focus to
search for naturally occurring antioxidants to be used in
food, cosmetics, pharmaceutics, and medicinal products [7].
Among several neurological disorders, Alzheimer’s
disease (AD) is a progressive neurodegenerative disorder
and the most prevalent cause of dementia in elderly people
(in 2019 ADI estimated that there are over 50 million people
living with dementia globally) [8, 9]. Although not fully
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understood, the “cholinergic hypothesis” proposes that the
neurodegenerative mechanism is a decline of the neuro-
transmitter acetylcholine in the brain. +e drugs presently
used to treat AD patients act as enhancers of the acetyl-
choline level in the brain, responsible for central cholinergic
transmission [10]. After being delivered across neuronal
synapses, acetylcholine is hydrolyzed to a choline and an
acetyl group by the enzyme acetylcholinesterase [8].
+erefore, applying inhibitors of acetylcholinesterase, ace-
tylcholine is not hydrolyzed, maintaining its activity as a
neurotransmitter [11, 12]. However, some of the drugs
approved for the treatment of AD symptoms show hepa-
totoxicity [12], higher risk of urinary incontinence [13],
increased risk of bradycardia and other cardiovascular ad-
verse effects [14], pulmonary disorders [15], and involuntary
weight loss [16], and the search continues for new drugs that
are more efficient in brain penetration, less harmful, and
with high bioavailability [12].
+e acetylcholinesterase enzyme (AChE) is an attractive
target for the discovery of mechanism-based inhibitors
because of its role in hydrolysis of the neurotransmitter
acetylcholine. AChE inhibitors as rivastigmine [17], done-
pezil, or galantamine [18] are currently the most effective
agents to treat cognitive symptoms of AD and have other
possible therapeutic applications in the treatment of other
neurodegenerative disorders. Recently, research on pre-
vention and treatment of Alzheimer has focused on naturally
occurring acetylcholinesterase (AChE) inhibitors from
plants, namely, polyphenolic compounds such as flavonoids
with inhibitory capacity similar to that of the currently
prescribed AChE inhibitor drugs [17–22], of which the al-
kaloid galantamine is a perfect example [18].+is compound
offers the advantage of being better tolerated and cheaper,
since it is commonly found in foods, and its antioxidant
activity and strong metal chelator capability may also
contribute to the decrease of the oxidative stress that affects
tissues associated with Alzheimer’s disease [8].
+is study considers cork, the outer bark from Quercus
suber, a potential natural source of bioactive compounds.
Cork has a high proportion of lipophilic and polar me-
tabolites [23]. +e detailed composition of cork lipophilic
extracts has been investigated, showing that they are mainly
composed by aliphatics, phenolics, and triterpenes [24]. +e
information available on the ethanol and water extracts is
scarce, but they are rich in phenolic compounds and have
relatively high antioxidant activity as radical scavengers [25].
+e cork material has peculiar and unique properties such as
high elasticity and low permeability that allows several
applications, such as wine stoppers and thermal or acoustic
insulators, thereby building up an economically relevant
cork industry [26]. +e residues produced by the cork-based
industries may be an inexpensive source of substances with
useful chemical characteristics and properties.
+e aim of this study is to investigate the ethanol-water
extracts of cork and of the corkback residues as prospective
new sources of compounds with both antioxidant and
acetylcholinesterase inhibitory activity that could potentially
be applied in the treatment of neurodegenerative disorders
such as AD.
2. Materials and Methods
2.1. Plant Material. Cork and corkback samples were ob-
tained from Quercus suber collected in Herdade da Con-
tenda (Moura, Portugal) and made available as planks by a
cork processing unit from Amorins&Irmãos situated in
Lordelo, Santa Maria da Feira, Portugal.
+e cork and corkback samples were separated manually
with a scalpel and then air-dried in controlled indoor
conditions regarding humidity and temperature, in the
absence of light. +e corkback is the outer layer of the cork
plank; it is the phloemic layer that remains to the outside
when the underlying periderm is formed and the cork layer
produced (Pereira [26]).
+e samples were ground individually in a cutting mill
(Retsch SM 2000) using an output sieve with
10mm× 10mm openings, followed by a second pass with a
2mm× 2mm output sieve, and then fractionated with a
vibratory system (Retsch AS 200basic) with standard sieves
with the following mesh sizes: 80 (0.180mm), 60
(0.250mm), 40 (0.425mm), 20 (0.850mm), and 15 (1mm).
After sieving, the 2.0–1.0mm and 0.45–0.25mm fractions
were collected for chemical analysis.
Fractioning of cork and corkback samples was done in
triplicate.
2.2. Chemicals. +e following chemicals were supplied by
Sigma-Aldrich (St. Louis, MO, USA): dichloromethane,
ethanol, gallic acid (GA), Folin–Ciocalteu reagent, sodium
carbonate (Na2CO3), catechin (CA), sodium hydroxide
(NaOH), sodium nitrate (NaNO2), aluminium chloride
(AlCl3), 2,2-diphenyl-1-picryhydrazyl (DPPH), 2,4,6-tri-
pyridyl-s-triazine (TPTZ), sodium acetate (NaOCH3),
FeCl3.6H2O, 6-hydroxy-2,5,7,8-tetramethylchroman-2-car-
boxylic acid (Trolox), acetylcholinesterase (AChE) from
electric eel (type VI-S 349 U/mg solid, 411mg/U protein),
5,5′-dithio-bis-[2-nitrobenzoic acid] (DTNB), and substrate
acetylthiocholine iodide (AChI). For the preparation of
buffer, dipotassium hydrogen phosphate (K2HPO4) and
potassium hydroxide (KOH) both from Acros Organics
(Pittsburgh, PA, USA) were used (extra pure analytical
grade).
2.3. Preparation of Extract Solutions. +e fractionated cork
and corkback samples were first submitted to a successive
extraction in a Soxhlet apparatus, using dichloromethane for
6 h. Ethanol-water extracts were obtained using an ethanol-
water solvent solution 70 : 30 (v : v) by the same method-
ology, during 48 h (Figure 1).
2.4. Total Phenolic and Total Flavonoid Contents. +e total
phenolic content (TPC) of the ethanol-water extracts of cork
and corkback samples was determined using a modified
Folin–Ciocalteu colorimetric method [27], in which a
phosphowolframate-phosphomolybdate complex is reduced
in the presence of phenolic compounds. A 100 μL aliquot of
each cork and corkback ethanol-water extract was added to
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4mL of Folin–Ciocalteu reagent and vortexed to homoge-
nize the mixture. After 8min at room temperature, 4mL of
7.5% Na2CO3 solution was added and properly mixed. +e
mixture was incubated in a thermostatic bath at 45oC for
15min. +e absorbance of the resulting blue colored mix-
tures was recorded in a spectrophotometer (UV-160A Re-
cording Spectrophotometer, Shimadzu) at 765 nm against a
blank containing only water. A gallic acid (GA) standard
calibration curve (solutions within the range of concen-
trations 0–0.6 g/L) was used as a reference to measure the
TPC. +e experiment was conducted in triplicate, and the
TPC was expressed as mg gallic acid equivalent (GAE) per g
of extract (mean± SD).
+e total flavonoid content (TFC) was determined
using a modified methodology described by Singleton et
al. [28]. Aliquots of 1mL of cork and corkback ethanol-
water extracts were diluted in 4mL of distilled water and
0.3mL of 5% (m/v) NaNO2 was added. After 5min in the
dark, 0.3 mL of 10% (m/v) AlCl3 was added and, 6min
later, 2 mL of 4% (m/v) NaOH and 2.4 mL of distilled
water was added sequentially and properly mixed. Ab-
sorbance of the mixture was measured at 506 nm after
30min of incubation against water (UV-160A Recording
Spectrophotometer, Shimadzu). A catechin (CE) standard
curve (solutions within the range of concentrations
0.10–1.0 mg/mL) was used as reference to measure the
TFC. +e experiment was conducted in triplicate, and the
TFC was expressed as mg catechin equivalent (CE) per g
of extract (mean ± SD).
2.5. Antioxidant Activity. Two methods were used for the
determination of the antioxidant activity of the ethanol-
water extracts from the cork and corkback samples: 2,2-
diphenyl-1-picryhydrazyl (DPPH) assay, which measures
the free radical scavenging capacity, and ferric reducing
antioxidant power (FRAP). It is important to carry out more
than one type of antioxidant capacity measurement to cover
the various mechanisms of antioxidant action of a plant
extract [29].
2.5.1. DPPH Assay. +e DPPH assay was performed
according to the method described by Abdulwahab et al.
with some modifications [30]. It uses 2,2-diphenyl-1-pic-
rylhydrazyl hydrate (DPPH), a nitrogen centered free radical
having an odd electron which gives a strong absorption at
517 nm, and its color changes from purple to yellow when
the odd electron is paired off in the presence of a radical
scavenger to form the reduced DPPH-H [31]. Fresh DPPH
solution was prepared by diluting 10mL of stock solution
(1M) in 90mL methanol. +e DPPH results are expressed
either as IC50 value or as Trolox equivalents on a dry extract
base. Stock solutions of the cork and corkback ethanol-water
extracts were prepared in the following concentrations:
0.27mg/ml and 0.05mg/ml for cork extracts from 1-2mm
and 0.25–0.45mm fractions and 0.03mg/ml and 0.07mg/ml
for corkback extracts from 1-2mm and 0.25–0.45mm
fractions, respectively. Briefly, 1mL of standard solutions
and extracts was placed in test tubes and mixed with 3.9mL
of a DPPHmethanol solution.+e blank sample consisted of
1mL of methanol added to 3.9mL of DPPH solution. After
30min incubation at room temperature in the dark, the
absorbance was measured at 517 nm. Trolox is a water-
soluble antioxidant, which was synthesized as a vitamin E
derivative in 1974 [32]. Trolox has been used as a standard
antioxidant for antioxidant capacity assays. +e radical
scavenging activity of each sample was expressed as IC50
(concentration of an inhibitor that results in a half-maximal
inhibition of a response, i.e., the concentration that reduces a
response to 50% of its maximum). +e % inhibition of both
standards and samples was calculated by the DPPH inhi-
bition percentage as follows: I %� [(Abs0 −Abs1)/Abs0]×
100, where Abs0 was the absorbance of the blank and Abs1
was the absorbance of the sample at different concentrations
and graphs were plotted (% inhibitions versus concentra-
tion). +e scavenging effect of each extract on the DPPH
radical was also expressed as the Trolox equivalent anti-
oxidant capacity (TEAC) determined from the calibration
curve with Trolox solution of different concentrations and
the percentage of scavenging effect on the DPPH radical.
Each experiment was carried out in triplicate.
Q. suber
cork and corkback
Grinding Fractioning Soxhlet extraction(dichloromethane)
60 mesh
Other fractions
Soxhlet extraction
(ethanol/water)
70 : 30 (v/v)
Purified extracts and
bioactive compounds
Bioactive compounds
AChE in vitro assays
Figure 1: Scheme of the followed methodology towards the in vitro assays with AChE.
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2.5.2. Ferric Reducing Antioxidant Power Assay. +e ferric
reducing antioxidant power (FRAP) assay depends on the
reduction of ferric ion into ferrous ion [33]. A fresh working
solution of FRAP reagent was obtained by mixing 25mL
300mM sodium acetate buffer (pH 3.6), 2.5mL 10mM
TPTZ solution, and 2.5mL 20mM FeCl3.6H2O solution and
warming at 37 oC before use. An aliquot (100 μL) of the cork
and corkback ethanol-water extracts or of the standard was
then added to 2.7mL of FRAP reagent and 270 μL of distilled
water and the reaction mixture was incubated at 37°C for
30min in the dark. +e absorbance of the colored ferrous
tripyridyltriazine complex was measured at 593 nm in
comparison with a blank. Trolox was used for positive
control and results are expressed in μg Trolox equivalent.
2.6. Acetylcholinesterase Activity. +e acetylcholinesterase
(AChE) activity was assayed following an adaptation of the
spectrophotometric method reported by Ellman et al. [34].
+e cuvette used as a blank to control for the nonenzymatic
hydrolysis of acetylcholine contained a mixture of 500 μL of
3mM DTNB solution (in 0.1M potassium phosphate pH 8),
100 μL of 15mMAChI (in water), 275 μL of 0.1M potassium
phosphate pH 8, and 100 μL of each cork and corkback
ethanol-water extract solutions at the different concentra-
tions evaluated (0.1mg/mL, 0.5mg/mL, 1.0mg/mL, and
2.0mg/mL). In the reaction cuvette, 25 μL of buffer was
replaced by AChE solution 0.16 U/mL. +e resulting solu-
tions were placed in a spectrophotometer. +e thiocholine
formed during the hydrolysis of acetylcholine reacts rapidly
with DTNB and a yellow compound is formed. +e reaction
was monitored for 5min at 405 nm and the absorbance
registered every minute. Velocities of reaction were calcu-
lated. Enzyme activity was calculated as a percentage of the
velocities compared to that of the assay using buffer solution
instead of inhibitor (cork or corkback ethanol-water ex-
tracts). +e assays were performed in triplicate.
3. Results and Discussion
3.1. Total Phenolic and Total Flavonoid Contents. Table 1
presents the extraction yields, TPC, and TFC of the ethanol-
water extracts of the cork and corkback samples with
granulometry of 2-1mm and 0.45–0.25mm.
+e yields of the lipophilic extracts of cork were
similar for both granulometric fractions (on average
6.5%), in line with the 5-8% values reported by Pereira
[23] for Q. suber cork, and averaged 2.7% for corkback,
which is lower than the 4.4% reported by Pereira and
Baptista [35].
+e ethanol-water extraction yields of cork (1.8% and
4.0%) were below the range reported in the literature in
ethanol-water extraction (varying between 7.1% and 8.3%
according to Aroso et al. [36]. In corkback samples, the
coarse fraction showed a high extraction yield (around 8%),
while the fine fractions only yielded 1.5%. +e differences in
granulometric fraction yields are expected since, upon
grinding, these fractions show specific structural features
[37, 38]. In the case of cork, materials other than the cork
cells may be present, e.g., lignified sclereids or lenticular
filling material that will preferentially be present in the finer
fractions thereby leading to chemical differences [37]. +e
influence of time and solvent’s volume on the extraction
yield was not evaluated in this study.
+e total phenolic contents in the ethanol-water extracts
of corkback and cork samples are in the range of
387.4–435.1mg GAE/g extract and 189.9–202.9mg GAE/g
extract, correspondingly. When expressed in g GAE/kg of
tissue, the total phenolic content ranged from 3.6 to 7.6 g
GAE/kg of dry cork which is in line with those obtained in
several other plant materials, but it was significantly higher
for the corkback tissue (5.8–36.1 g GAE/kg of dry corkback)
[25, 39, 40]. +e TPC did not differ significantly between
granulometric fractions, although it is considerably higher in
corkback than in cork tissues.
TFC are also remarkably higher in corkback extracts
(127.4–241.4mg CE/g extract) in relation to the cork ex-
tracts. +ese differences were to be expected given the
different anatomical origin and chemical composition of
both materials. +e corkback layer is of phloemic nature,
constituted by a layer of nonconducting phloemic tissue that
was isolated by the formation of an underlying periderm
[26, 41].
3.2. Antioxidant Activity. +e antioxidant activity of the
ethanol-water extracts from cork and corkback was evalu-
ated by DPPH and FRAP tests. Table 1 shows the antioxidant
activity of the studied extracts, expressed in terms of the
amount of extract required to reduce into 50% the DPPH
concentration (IC50), as well as in terms of the Trolox
equivalent antioxidant activity (TEAC) on an extract cork/
corkback basis (mg TEAC/g extract). For FRAP assay, re-
sults are expressed in mM TEAC/g extract and mg Fe2+/g
extract. +e IC50 value for Trolox was also obtained and
reported for comparative purposes (IC50 Trolox in ethanol
3.2 μg Trolox/mL).
Plant polyphenols can act as free radical scavengers,
especially flavonoids that may be potent antioxidants and
applied against several diseases. +eir specific chemical
structure determines the ability of capturing the harmful free
radicals [42]. To our knowledge, little is known about the
antioxidant activity of corkback extracts. Our first obser-
vations give us the idea that particle size has no clear in-
fluence on the antiradical or reducing ability properties of
extracts. Overall, both cork and corkback extracts showed
good antioxidant properties and no evident differences were
found between the two granulometric fractions. +ese
ethanol-water extracts have revealed an antioxidant activity
quite similar to the Trolox standard in terms of IC50; in fact,
cork extracts have an IC50 similar to Trolox (3.2 μg extract/
mL) and a little higher for corkback extracts (4.0–5.3 μg
extract/mL).+ese values are in line with the results reported
by Santos et al. [25] for Q. suber cork extracts of different
ethanol-water polarity (2.79 in water extract, 3.58 in
methanol, and 5.84 in methanol-water 50 : 50 extract).
+ese results are promising since cork and corkback
polar (ethanol-water) extracts can be used as a source of
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potential natural antioxidants in nutraceutical applications
or material surfacing protection.
3.3. Acetylcholinesterase Activity. In this study, the AChE
inhibitory activity of the extracts expressed as IC50 values,
calculated from the regression equations obtained from the
activity of samples at different concentrations, was found to
increase dose-dependently (Figure 2).
Overall, the corkback ethanol-water extracts showed
higher inhibitory activity at all assayed concentrations
(0.1–2.0mg/mL) when compared to cork extracts, being
superior in the ones with lower particle sizes. +e same
tendency was observed for the cork extracts.
At the highest assayed dose (2.0mg/mL), the percent
inhibitory effect was on average 62.2% in both granulometric
fractions of corkback extracts, showing no significant dif-
ferences between them. In fact, for concentrations equal to
or higher than 0.5mg/mL, the acetylcholinesterase inhibi-
tory activity was always higher than 60% for corkback ex-
tracts, with no considerable increase above 1.0mg/mL.
However, at the lower assayed dose (0.1mg/mL) the in-
hibitory effect was considerably lower, ranging from 42.4%
to 48.6%.
+e ethanol-water cork extracts showed an overall lower
inhibitory effect, being around 48.9% at the higher assayed
dose (2.0mg/mL) and 26.2% at the lower assayed dose
(0.1mg/mL). +e ethanol-water cork extracts displayed a
nearly constant acetylcholinesterase inhibitory activity of
47.0% and 50.8% with extract concentrations equal to or
greater than 1.0mg/mL for cork particles of 2-1mm and
0.45–0.25mm, respectively (Figure 2).
Our results are within the range of the values found for
the inhibition of this enzyme by plant extracts [43]. In fact,
the results obtained for corkback extracts were better than
the ones found for the standard galantamine (48.8% at
1.0mg/mL) [44]. Galantamine is usually extracted from
various species of Amaryllidaceae family as snowdrop,
daffodil, and snowflake, which are scarce and threatened
botanical sources supplies [45]. Extraction procedures,
isolation, and purification steps are rather time consuming
and highly costly, and therefore several synthetic protocols
have been developed over the years, resulting in method-
ologies that can prepare galantamine in a few steps, in
racemic or in enantiomerically pure form. However, these
methodologies involve the use of toxic solvents and reagents
and the yields of the resulting product range from low to
moderate [45]. +e major advantage on using cork and
corkback extracts as AChE inhibitors relies on the fact that
these raw materials are readily available residues of cork
industry, contributing to a circular bioeconomy in which
waste is converted to added-value products, supporting
some of the 2030 agenda goals for sustainable development
which supports rural activities’ development, economic
growth, social inclusion, and environmental protection.
[46].
When comparing the acetylcholinesterase inhibitory
activity with the overall phenolic and flavonoid contents of
the extracts, we can see a positive direct correlation between
them (Figure 3), as usually expected for plant extracts since
these compounds have been previously reported to be potent
agents for treating and combatting Alzheimer’s disease
[47, 48]. However, concerning the differences between
granulometric fractions, TPC and TFC are higher in coarser
fractions, whereas acetylcholinesterase inhibitory activity is
smaller.
+e results obtained are promising for both cork and
corkback ethanol-water extracts as inhibitors of the ace-
tylcholinesterase enzyme.
Table 1: Lipophilic and polar extracts yields, composition in terms of total phenolic and total flavonoid contents, and antioxidant activity of
ethanol-water extracts of cork and corkback samples from Quercus suber with particle sizes of 2-1mm and 0.45–0.25mm.
Corkback Cork
2-1mm 0.45–0.25mm 2-1mm 0.45–0.25mm
Extraction yield of CH2Cl2 extract (%) 1.8± 0.1 3.6± 0.2 6.3± 1.0 6.6± 0.4
Extraction yield of EtOH-water extract (%) 8.3± 0.2 1.5± 0.1 1.8± 0.4 4.0± 0.1
Total phenolic (mg GAE/g extract) 435.1± 8.1 387.4± 11.1 202.9± 10.2 189.9± 19.6
Total flavonoid (mg CE/g extract) 127.4± 77.5 241.4± 84.3 90.0± 30.4 82.4± 8.7
Antioxidant capacity (mg TEAC/g extract) 57.4± 1.30 66.3± 0.1 19.6± 1.6 21.0± 0.2
IC50 values (μg extract/mL)∗ 4.0± 0.1 5.2± 0.0 3.2± 0.1 3.2± 0.4
FRAP (mM TEAC/g extract) 9.2± 0.1 8.2± 0.2 3.1± 0.1 3.0± 0.1
FRAP (mg Fe2+/g extract) 9222.4± 36.3 8120.5± 27.2 2995.3± 19.6 2991.9± 41.6
GAE: gallic acid equivalent; CE: catechin equivalent; TEAC: Trolox equivalent antioxidant capacity; FRAP: ferric ion reducing antioxidant potential.
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Figure 2: Influence of the cork and corkback ethanol-water ex-
tracts concentration on acetylcholinesterase inhibition.
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4. Conclusions
To our knowledge, this is the first report characterizing ace-
tylcholinesterase inhibition together with antioxidant activities
and phenolic contents of Q. suber cork and corkback ethanol-
water extracts. +ese extracts show significant antioxidant
activity against DPPH and FRAP, with a positive correlation
between the phenolic and flavonoid contents. Corkback eth-
anol-water extracts, and cork extracts to a smaller extent, also
showed an interesting inhibitory activity against acetylcho-
linesterase enzyme, resulting in their possible valorization as an
accessible source of natural antioxidants and anti-
acetylcholinesterase agents in pharmaceutical or nutraceutical
formulations with health benefits.
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